Literature DB >> 1356511

Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma.

G Gaidano1, R S Hauptschein, N Z Parsa, K Offit, P H Rao, G Lenoir, D M Knowles, R S Chaganti, R Dalla-Favera.   

Abstract

The recurrent loss of genetic material from a specific chromosomal region in a given tumor type suggests the presence of a tumor-suppressor gene, the loss or inactivation of which may be relevant for tumorigenesis. In this study, we provide molecular evidence for the recurrent association between deletions on the long arm of chromosome 6 and B-cell non-Hodgkin lymphoma (B-NHL). Normal and tumor DNAs from 71 cases of B-NHL were studied for loss of constitutional heterozygosity (LOH) at 19 loci on chromosome 6 using a panel of restriction fragment length polymorphism (RFLP) probes. LOH, indicating deletion of all or part of 6q, was detected in 16 of 71 cases (22.5%), ranging from low-grade to high-grade B-NHL. The isolated loss of 6p or the loss of other chromosomes (8, 17, 22) tested as controls for specificity was not observed in any case. Comparison of the extent of the deletions among different cases allowed the identification of two distinct regions of minimal deletion (RMD) at 6q25 to 6q27 (RMD-1) and at 6q21 to 6q23 (RMD-2), respectively, suggesting the existence of two tumor-suppressor genes. These data support a role for 6q deletions in B-NHL pathogenesis and provide a basis for identifying the corresponding tumor-suppressor genes.

Entities:  

Mesh:

Year:  1992        PMID: 1356511

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

1.  Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas.

Authors:  H Dannenberg; E J Speel; J Zhao; P Saremaslani; E van Der Harst; J Roth; P U Heitz; H J Bonjer; W N Dinjens; W J Mooi; P Komminoth; R R de Krijger
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization.

Authors:  E J Speel; J Richter; H Moch; C Egenter; P Saremaslani; K Rütimann; J Zhao; A Barghorn; J Roth; P U Heitz; P Komminoth
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 3.  Genetic abnormalities in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.

Authors:  M Merup
Journal:  Med Oncol       Date:  1998-07       Impact factor: 3.064

4.  Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders.

Authors:  S Stilgenbauer; P Liebisch; M R James; M Schröder; B Schlegelberger; K Fischer; M Bentz; P Lichter; H Döhner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

5.  The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma.

Authors:  Elisa Oricchio; Gouri Nanjangud; Andrew L Wolfe; Jonathan H Schatz; Konstantinos J Mavrakis; Man Jiang; Xiaoping Liu; Joanne Bruno; Adriana Heguy; Adam B Olshen; Nicholas D Socci; Julie Teruya-Feldstein; Frances Weis-Garcia; Wayne Tam; Rita Shaknovich; Ari Melnick; Juha P Himanen; R S K Chaganti; Hans-Guido Wendel
Journal:  Cell       Date:  2011-10-28       Impact factor: 41.582

6.  Analysis of chromosome 6 deletions in lymphoid malignancies provides evidence for a region of minimal deletion within a 2-megabase segment of 6q21.

Authors:  T Sherratt; C Morelli; J M Boyle; C J Harrison
Journal:  Chromosome Res       Date:  1997-04       Impact factor: 5.239

7.  Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia.

Authors:  G Gaidano; E W Newcomb; J Z Gong; V Tassi; A Neri; A Cortelezzi; R Calori; L Baldini; R Dalla-Favera
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

8.  Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma.

Authors:  A Migliazza; S Martinotti; W Chen; C Fusco; B H Ye; D M Knowles; K Offit; R S Chaganti; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

9.  Cytogenetic findings in 175 patients indicate that items of the Kiel classification should not be disregarded in the REAL classification of lymphoid neoplasms.

Authors:  H Nowotny; H Karlic; H Grüner; J Hirsch; M Vesely; A Nader; R Heinz
Journal:  Ann Hematol       Date:  1996-05       Impact factor: 3.673

Review 10.  Molecular pathology of AIDS-related lymphomas. Biologic aspects and clinicopathologic heterogeneity.

Authors:  G Gaidano; C Pastore; C Lanza; U Mazza; G Saglio
Journal:  Ann Hematol       Date:  1994-12       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.